Drugs that contain Aliskiren Hemifumarate; Hydrochlorothiazide

1. Tekturna Hct patents expiration

TEKTURNA HCT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023893 NODEN PHARMA Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Mar, 2022

(1 year, 8 months ago)

US8618172 NODEN PHARMA Galenical formulations of organic compounds
Jul, 2028

(4 years from now)

Market Authorisation Date: 18 January, 2008

Treatment: NA


How can I launch a generic of TEKTURNA HCT before it's drug patent expiration?
More Information on Dosage

TEKTURNA HCT family patents

Family Patents